0000899243-23-015764.txt : 20230616 0000899243-23-015764.hdr.sgml : 20230616 20230616161510 ACCESSION NUMBER: 0000899243-23-015764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cunningham Emmett CENTRAL INDEX KEY: 0001710382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 231021274 MAIL ADDRESS: STREET 1: C/O RESTORATION ROBOTICS, INC. STREET 2: 128 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-14 0 0001563577 Galera Therapeutics, Inc. GRTX 0001710382 Cunningham Emmett C/O CLARUS VENTURES 314 MAIN ST., 15TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 0 Stock Option (Right to Buy) 3.27 2023-06-14 4 A 0 48000 0.00 A 2033-06-13 Common Stock 48000 0 D This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of Blackstone Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises. Dr. Cunningham, an employee of an affiliate of Blackstone, is a member of the board of directors of the issuer. Dr. Cunningham disclaims beneficial ownership of any securities of the issuer that may be deemed to be beneficially owned by affiliates of Blackstone. /s/ Emmett Cunningham 2023-06-16